TFE3 and renal cell carcinoma: At the one-year follow-up, the patient recovered well without receiving any adjuvant therapy.<h4>Conclusion</h4>This study elucidates the natural history, diagnosis, and management of TFE3-RCC, underscoring the critical importance of early surgical intervention.